"Mercy UC Davis Cancer Center is a cancer center that offers many services, including cancer treatment, advance directive planning, and clinical trials. Visit Mercy UC Davis Cancer Center located at 3850 G St, Merced, CA. This Merced cancer center is one of the best in California. As part of the Dignity Health network, Mercy UC Davis Cancer Center is dedicated to delivering high quality, compassionate care and access to Merced and nearby communities."

During the past decade, Mercy UC Davis Cancer Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 14 clinical trials were completed, i.e. on average, 155.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy UC Davis Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy UC Davis Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Mercy UC Davis Cancer Center" are "Breast Cancer" (4 trials), "Prostate Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Lung Cancer" (2 trials) and "Minimally Invasive Lung Adenocarcinoma" (2 trials). Many other conditions were trialed in "Mercy UC Davis Cancer Center" in a lesser frequency.

Most popular intervention types in "Mercy UC Davis Cancer Center" are "Drug" (20 trials), "Other" (14 trials), "Radiation" (5 trials), "Biological" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials), "Paclitaxel" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mercy UC Davis Cancer Center" are 19 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy UC Davis Cancer Center". undefined are not yet recruiting, 1 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mercy UC Davis Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy UC Davis Cancer Center, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".